0 Σχόλια
0 Μοιράστηκε
373 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Asia Pacific SGLT2 Inhibitors Market: Regional Growth Trends and Industry OutlookThe Asia Pacific SGLT2 Inhibitors Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Asia Pacific SGLT2 Inhibitors Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape,...0 Σχόλια 0 Μοιράστηκε 768 Views 0 Προεπισκόπηση
-
North America SGLT2 Inhibitors Market: Emerging Trends in Diabetes ManagementPolaris Market Research today announced findings from its latest report, projecting the North America SGLT2 Inhibitors Market to grow from USD 7.32 billion in 2024 to USD 16.37 billion by 2034, at a CAGR of 8.4% during 2025–2034. The report profiles 10 leading companies across four segmentation categories: indication, drug, distribution channel, and country. Rising obesity, type 2...0 Σχόλια 0 Μοιράστηκε 29 Views 0 Προεπισκόπηση
-
SGLT2 Inhibitors Market Gains Momentum with Growing Adoption of Advanced TherapiesSGLT2 Inhibitors Market for Diabetes Treatment Market is being significantly propelled by the well-documented cardiovascular and renal protective benefits of SGLT2 inhibitors beyond glycemic management. Landmark clinical trials such as EMPA-REG OUTCOME, CANVAS, and DECLARE-TIMI 58 have demonstrated statistically significant reductions in major adverse cardiovascular events (MACE),...0 Σχόλια 0 Μοιράστηκε 560 Views 0 Προεπισκόπηση
-
SGLT2 Inhibitors Market: Cardiometabolic Health, Drug Innovation & Emerging OpportunitiesAccording to a new report by Polaris Market Research, the global SGLT2 Inhibitors market was valued at USD 18.32 billion in 2025 and is projected to reach USD 33.51 billion by 2034, expanding at a CAGR of 6.90% over the forecast period. Growth is underpinned by rising cardiorenal treatment adoption, expanding type 2 diabetes prevalence, and accelerating new drug approvals across key...0 Σχόλια 0 Μοιράστηκε 337 Views 0 Προεπισκόπηση
-
Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση